LIMK1 and breast cancer: Based on survival analysis using the TCGA BC database (N = 3951), we found that a high level of LIMK1 (Fig. 4A), but a low level of miR-654-5p (Fig. S3B), was closely correlated with poor prognosis in patients with BC.